Investing Profile

Clare Ozawa

VCInvestor
Managing Director at Versant Ventures
Photo of Clare Ozawa, Managing Director at Versant Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Versant Ventures Managing Director
$100K - $5.0M
$1.5M
12
$102.2M
CompanyStageDateRound SizeTotal Raised
858 Therapeutics
Series BSep 2024$50M
Series ASep 2021$60M
$110M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA))
Gate Bioscience
Series ANov 2023$60M
$60M
Co-investors: Scott Biller (GV (Google Ventures)), Vineeta Agarwala (Andreessen Horowitz), Jay Parrish (ARCH Venture Partners)
Kate Therapeutics
Series AJun 2023$51M
$51M
Co-investors: Beth Seidenberg (Westlake Village BioPartners)
Lycia Therapeutics
Series BSep 2021$70M
$70M
Co-investors: Jeremy Caldwell (Versant Ventures)
LENZ Therapeutics
Series AJun 2021$47M
$47M
Co-investors: Zach Scheiner (RA Capital)
Capsida
Series AApr 2021$50M
$50M
Co-investors: Beth Seidenberg (Westlake Village BioPartners)
Pipeline Therapeutics
Series CFeb 2021$80M
Series BDec 2019$32M
$110M
Co-investors: Paul Grayson (Versant Ventures)
Oyster Point Pharmaceuticals
Series BFeb 2019$93M
Series ANov 2017$22M
Series ANov 2017$29M
$140M